Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-005135
Filing Date
2023-02-15
Accepted
2023-02-15 15:49:14
Documents
2
Period of Report
2023-02-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3963
2 EX-24 DOCUMENT attachment1.htm EX-24 4016
  Complete submission text file 0000899243-23-005135.txt   9607
Mailing Address C/O 3200 WALNUT ST BOULDER CO 80301
Business Address
Robbins Andrew R (Reporting) CIK: 0001590157 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38443 | Film No.: 23635252

Mailing Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451
Business Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451 617-945-5576
Cogent Biosciences, Inc. (Issuer) CIK: 0001622229 (see all company filings)

EIN.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations